hexamethonium has been researched along with Liver Dysfunction in 1 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kirstetter, P | 1 |
Moreau, R | 1 |
Soupison, T | 1 |
Cailmail, S | 1 |
Hartleb, M | 1 |
Lebrec, D | 1 |
1 other study available for hexamethonium and Liver Dysfunction
Article | Year |
---|---|
Role of sympathetic cardiovascular tone in control of arterial pressure in rats with cirrhosis.
Topics: Animals; Blood Pressure; Disease Models, Animal; Female; Hemodynamics; Hexamethonium; Liver Cirrhosi | 1996 |